Collaboration Under BARDA DRIVe Solving Sepsis Program to also Support Key Regulatory Path Activities to Advance Development of SBI-101(PRWeb September 02, 2021)Read the full story at https://www.prweb.com/releases/sentien_biotechnologies_partners_with_barda_to_evaluate_high_dose_cohort_in_phase_1_2_trial_of_sbi_101_for_treatment_of_acute_kidney_injury_associated_with_sepsis/prweb18166631.htm
